The Fentanyl and High Potency Drugs Operational Safety Training Course (Canada)

Dangers of Potential Exposure (DOPE) in the Workplace™

1 Day

Course Description

Are you or do you have the potential to be accidentally exposed to high potency drugs in the workplace? Do you know the risks associated with fentanyl or its analogues? Are appropriate measures in place to safely handle, process and secure found or seized high potency drugs? Do you know what actions to take in case of unprotected contact or medical emergency? This course is designed to provide an understanding of the dangers of high potency drugs, precautions for protection against exposure, how to identify overexposure and respond in emergencies.

**REA offers tailored fentanyl and high potency drug safety training to address the needs of a variety of workplace audiences. CLICK HERE

The Fentanyl and High Potency Drugs Operational Safety Training Course Curriculum

Expand All | Contract All

  • PART 1 - SCOPE OF THE FENTANYL PROBLEM
    • 1.1 Trends in community overdoses
    • 1.2 Fentanyl contribution to other drug overdoses
    • 1.3 Lethal doses of various opioids
    • 1.4 Trends in occupational encounters and exposures
  • PART 2 - OPIOID DRUGS - BASIC INFORMATION
    • 2.1 Key terminology and concepts
    • 2.2 Brief history of opioids
    • 2.3 The development of fentanyl
    • 2.4 Varieties of opioids and synthetic opioids
    • 2.5 Relative potency of opioids
    • 2.6 Natural, semi-synthetic and synthetic opioids
    • 2.7 Pharmacological action of opioids
    • 2.8 Therapeutic uses
    • 2.9 Production of the opioid "high"
    • 2.10 How do opioids create addiction?
    • 2.11 Symptoms of opioid withdrawal
  • PART 3 - ORIGINS OF THE CURRENT OPIOID EPIDEMIC
    • 3.1 Changing medical perspectives on pain relief
    • 3.2 Development of oxycodone
    • 3.3 Hospital accreditation standards for pain management
    • 3.4 Trends in oxycodone prescriptions
    • 3.5 Trends in oxycodone addictions
    • 3.6 Introduction of tamper resistant oxycodone tablets
    • 3.7 Impact of tamper resistant oxycodone on abuse of other opioids
  • PART 4 - BASIC INFORMATION ABOUT FENTANYL
    • 4.1 Reasons for original development
    • 4.2 Pharmacological characteristics
    • 4.3 Effects on the body
    • 4.4 Pharmaceutical forms and medical uses
    • 4.5 Potency of carfentanil
    • 4.6 Family of fentanyl analogues
    • 4.7 Weaponized use of carfentanil
    • 4.8 Signs of overexposure
    • 4.9 Overdose signs and symptoms
    • 4.10 Overdose treatment
    • 4.11 Naloxone opioid antagonism
    • 4.12 Naloxone administration formats
  • PART 5 - THE INTERNATIONAL AND DOMESTIC FENTANYL SUPPLY CHAIN
    • 5.1 Production in China and pathways for illegal importation into Canada and USA
    • 5.2 Production in Mexico and pathways for illegal importation into USA
    • 5.3 Third party country routing
    • 5.4 Ease of on-line purchase
    • 5.5 Domestic clandestine formulation labs
    • 5.6 Domestic clandestine pill production and format dilution
    • 5.7 Parties in the domestic dealer supply chain
  • PART 6 - POTENTIAL FOR OCCUPATIONAL EXPOSURE ALONG THE DOMESTIC SUPPLY CHAIN
    • 6.1 Key terminology and concepts
    • 6.2 Purity, quantity and potential contact frequency at supply chain points
    • 6.3 Occupations exposed to the supply chain contact points
    • 6.4 Risk and protective implications for various occupations
    • 6.5 Potential exposure incident statistics and cases
  • PART 7 - ROUTES OF EXPOSURE AND DOSING
    • 7.1 Fentanyl forms and routes of exposure
    • 7.2 The unknowns of dosing by incidental occupational exposure
    • 7.3 Penetration of the drug through skin and mucosa
    • 7.4 Skin contact, mucosal and respiratory incidental exposure and dose modelling
    • 7.5 Implications for health risks in field operations of different occupations in different settings
  • PART 8 - REVIEW OF GOVERNMENT AGENCY GUIDANCE
    • 8.1 United States NIOSH
    • 8.2 United States Department of Justice
    • 8.3 Canadian sources
    • 8.4 Critique
  • PART 9 - PROTECTIVE PRACTICES FOR WORKPLACES
    • 9.1 Exposure control logic for high potency drugs
    • 9.2 Form, drug and quantity-specific protective equipment recommendations
    • 9.3 Basic protective properties, limitations and usage of protective equipment
  • PART 10 - DECONTAMINATION AND DISPOSAL OF FENTANYL RESIDUES
    • 10.1 Types of objects
    • 10.2 Chemical methods for solvation and decontamination
    • 10.3 Solvation
    • 10.4 Oxydative degradation
    • 10.5 Empirical test data
    • 10.6 Decontamination methods for various objects, materials and surfaces
    • 10.7 Personnel and protective equipment decontamination
  • PART 11 - WORKPLACE HEALTH AND SAFETY LAWS AND PROGRAM ELEMENTS
    • 11.1 Jurisdiction-specific provisions establishing employer and worker duties
    • 11.2 Elements of a sound fentanyl occupational protection program
    • 11.3 Tailoring program elements to occupational risk exposure profiles
    • 11.4 Jurisdiction-specific duties to report and investigated suspected exposure incidents
  • PART 12 - FUTURE OUTLOOK FOR THE EPIDEMIC
    • 12.1 Review of perspectives on causes of the current epidemic
    • 12.2 Historical social and economic correlates of opioid epidemics in North America and Europe
    • 12.3 Regional correlation of addiction to de-industrialization and its consequences
    • 12.3 Role of the domestic controlled substances regulatory framework
    • 12.4 Role of controlled substances regulatory frameworks and enforcement practices in source countries
    • 12.5 Role of harm reduction efforts
    • 12.6 Economic and social factors
    • 12.7 Domestic programs to tackle the opioid epidemic
    • 12.8 Can we know for certain?

Registration Details

Cost*:

Public Price $695 plus tax
In-house Price** Please contact us

*Listed prices are "per registrant".
**Note on pricing for in-house courses at client site: minimum registrations apply and may include additional charges for travel and customization. Contact us for more information.

Upcoming Public Course Dates:

Please see our Terms and Conditions

Download OHS Training Calendar

How can I benefit from this course?

This course answers all the questions above and gives you an understanding of:

  • Basics of opiate and fentanyl chemistry and pharmacology
  • Emergence of the opioid epidemic and fentanyl in Canada
  • Legal and illicit supply chains and implications for potential exposure
  • Exposure dynamics in workplace settings
  • Exposure and health risk assessment
  • Protection practices for various exposure scenarios and settings
  • Decontamination practices
  • Symptoms of overexposure
  • Emergency response

Is this course for me?

This course is for workers in Police, EMS, Fire, Border Services, Corrections, Community Services, Hospital Emergency Staff, Housekeeping and Cleaning, and Utilities and Telecommunications.

Instructors

Dr. John H. Murphy BSc MHSc MBA PhD ROH CIH / Dr. Alejandro Colozo HBSc PhD MPH